Attached files
file | filename |
---|---|
8-K - FORM 8-K - ALKERMES INC | b85677e8vk.htm |
Exhibit 10.1
Fiscal 2012 Reporting Officer Performance Pay Plan
Philosophy
We support a pay-for-performance approach to variable compensation that rewards individual and
Company performance towards the achievement of our Company goals. This Plan is designed to provide
upside reward for outstanding Company and individual performance, motivate reporting officers to
focus on and work together toward achieving Company goals; and be competitive within our industry.
Eligibility
Company reporting officers are eligible to participate in the plan. As of April 1, 2011, the
following officers are eligible to participate in the Plan:
| Chief Executive Officer and President and Chairman of the Board of Directors |
| Senior Vice President, Chief Financial Officer and Treasurer |
| Senior Vice President, Corporate Development |
| Senior Vice President, Government Relations and Public Policy, General Counsel, Secretary and Chief Compliance Officer |
| Senior Vice President, Research and Development and Chief Medical Officer |
| Senior Vice President, Chief Operating Officer and Chief Risk Officer |
The performance period under the Plan consists of the twelve month period from April 1, 2011 to
March 31, 2012. To be eligible to participate in this Plan, the executive officer must be actively
employed by the Company at the time awards are paid by the Company. Performance pay awards will be
paid prior to two and one half months after the end of the performance period.
Individual Performance Pay Targets
An individual performance pay range and target as a percentage of base salary will be established
by the Compensation Committee of the Board of Directors of the Company for each of the reporting
officers and shall be based generally on comparable market data. Performance pay awards are to be
pro-rated based on the number of days employed in the performance period.
Company Objectives -
The Company objectives for fiscal 2012 are:
i) Manage relationships with key business partners,
ii) Successfully launch VIVITROL® into the opioid indication,
iii) Execute on the expanded development of our late stage product portfolio,
iv) Rapidly advance our emerging proprietary pipeline,
v) Efficiently supply clinical and commercial products,
vi) Achieve financial performance against guidance and
vii) Respond to changing business conditions
Individual Performance
Each individuals performance pay award under the Plan will be determined by the Compensation
Committee. Individual performance against the Company objectives affects the determination of each
individuals performance pay award relative to that individuals target performance pay amount. The
CEO of the Company shall provide the Compensation Committee with recommendations regarding the
performance pay for the Senior Vice Presidents. The percentage of base salary represented by each
performance pay award granted under the Plan shall fall within the target performance pay range.
The Compensation Committee reserves the right to modify the Plan, Company objectives or overall
payouts under the Plan at any time during the course of the fiscal year, including in response to
changing business goals, needs and operations.